Position in MRK
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$2,911,039
-$5,271 QoQ
Shares Held
22,654
-6.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#1,362
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LVW Advisors, LLC holds $27,389,756 across 12 Drug Manufacturers - General names. MRK ranks #5 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
24,697 | $6,272,297 | |
| 2 | ABBV |
AbbVie Inc.
|
19,932 | $5,015,688 | |
| 3 | LLY |
ELI LILLY & Co
|
3,596 | $4,313,150 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
23,396 | $2,955,850 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
22,654 | $2,911,039 | |
| 6 | AMGN |
Amgen Inc
|
7,208 | $2,610,160 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,426 | $1,004,086 | |
| 8 | AZN |
Astrazeneca PLC
|
5,241 | $993,798 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,911,039 | 22,654 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $2,916,310 | 24,244 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $2,607,395 | 24,771 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,639,320 | 19,532 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,497,469 | 18,917 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,306,815 | 14,559 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $1,041,854 | 10,473 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $888,039 | 7,820 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $840,849 | 6,792 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $852,924 | 6,464 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $633,188 | 5,808 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $693,368 | 6,735 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $1,127,129 | 9,768 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $1,583,721 | 14,886 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,757,669 | 15,842 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $1,418,568 | 16,472 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $1,530,014 | 16,782 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $1,383,198 | 16,858 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $1,229,075 | 16,037 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $1,172,692 | 15,613 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $1,149,907 | 14,786 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $651,256 | 8,448 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $509,613 | 6,230 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $486,004 | 5,859 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $440,007 | 5,690 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $454,176 | 5,903 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||